Cargando…

Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is an established risk factor for diabetes, cardiovascular disease, antiviral treatment resistance, and progression of chronic hepatitis C virus (HCV) infection to fibrosis. Apolipoprotein-B 100 (ApoB-100) is a dyslipidemia marker and steatosis pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ming-Shyan, Guo, Su-Er, Lin, Huang-Shen, Hsu, Jen-Te, Lin, Yu-Sheng, Lin, Tsai-Hui, Huang, Tung-Jung, Chen, Mei-Yen, Chung, Chang-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger GmbH 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644880/ https://www.ncbi.nlm.nih.gov/pubmed/27054361 http://dx.doi.org/10.1159/000443692

Ejemplares similares

Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study
por: Lin, Ming-Shyan, et al.
Publicado: (2015)

Waist-to-height ratio is a useful index for nonalcoholic fatty liver disease in children and adolescents: a secondary data analysis
por: Lin, Ming-Shyan, et al.
Publicado: (2017)

Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area
por: Hu, Jing-Hong, et al.
Publicado: (2016)

Alcohol, betel-nut and cigarette consumption are negatively associated with health promoting behaviors in Taiwan: A cross-sectional study
por: Guo, Su-Er, et al.
Publicado: (2013)

Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in Taiwan
por: Lin, Ming-Shyan, et al.
Publicado: (2019)

Prevalence of and factors associated with adopting bone health promoting behaviours among people with osteoporosis in Taiwan: a cross-sectional study
por: Chen, Po-Han, et al.
Publicado: (2017)

Health Inequality among Fishery Workers during Climate Change: A National Population-Based and Retrospective Longitudinal Cohort Study
por: Lin, Ming-Shyan, et al.
Publicado: (2022)

Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression
por: Bruinstroop, Eveline, et al.
Publicado: (2021)

Alanine aminotransferase to aspartate aminotransferase ratio and hepatitis B virus on metabolic syndrome: a community-based study
por: Lin, Ming-Shyan, et al.
Publicado: (2022)

Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis
por: Lin, Haixia, et al.
Publicado: (2022)

Bisphenol A Coupled with a High-Fat Diet Promotes Hepatosteatosis through Reactive-Oxygen-Species-Induced CD36 Overexpression
por: Lee, Jyun-Lin, et al.
Publicado: (2022)

Ameliorative effects of functional crude-chalaza hydrolysates on the hepatosteatosis development induced by a high-fat diet
por: Chen, Jr-Wei, et al.
Publicado: (2021)

PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis
por: Zhang, Wenjie, et al.
Publicado: (2015)

Lung function impairment and cardiometabolic risks among rural adults: implication for an aging society
por: Lin, Yu-Chih, et al.
Publicado: (2021)

Pepsin-digested chicken-liver hydrolysate attenuates hepatosteatosis by relieving hepatic and peripheral insulin resistance in long-term high-fat dietary habit
por: Wu, Yi-Hsieng Samuel, et al.
Publicado: (2021)

Nutrigenomics Therapy of Hepatisis C Virus Induced-hepatosteatosis
por: Liu, Qing, et al.
Publicado: (2010)

The Doppler Ultrasonographic Evaluation of Hemodynamic Changes in Hepatic Vascular Structures in Patients with Hepatosteatosis
por: Karasin, Mehmet, et al.
Publicado: (2014)

Ceramides: Nutrient Signals that Drive Hepatosteatosis
por: Summers, Scott A.
Publicado: (2020)

Inhibition of Aldose Reductase Activates Hepatic Peroxisome Proliferator-Activated Receptor-α and Ameliorates Hepatosteatosis in Diabetic db/db Mice
por: Qiu, Longxin, et al.
Publicado: (2012)

Factors associated with having less than 20 natural teeth in rural adults: a cross-sectional study
por: Tsai, Su-Jen, et al.
Publicado: (2015)

The relationship between vitamin D level and hepatosteatosis in obese children
por: Dursun, Fatma, et al.
Publicado: (2018)

Hepatosteatosis from Lysosomal Acid Lipase Deficiency
por: Zandanell, Stephan, et al.
Publicado: (2018)

Role of hepatosteatosis in the prognosis of COVID 19 disease
por: Çoraplı, Mahmut, et al.
Publicado: (2021)

Hepatitis B Co-Infection Has Limited Impact on Liver Stiffness Regression in Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals
por: Hsu, Cheng-Er, et al.
Publicado: (2022)

Detection of Impaired Cognitive Function in Rat with Hepatosteatosis Model and Improving Effect of GLP-1 Analogs (Exenatide) on Cognitive Function in Hepatosteatosis
por: Erbaş, Oytun, et al.
Publicado: (2014)

Impact of Chronic Kidney Disease on Short-Term Cardiac Implantable Electronic Device Related Infection: A Nationwide Population-Based Cohort Study
por: Lin, Yu-Sheng, et al.
Publicado: (2016)

Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in long-term care facilities in eastern Taiwan
por: Tsai, Hsin-Chi, et al.
Publicado: (2019)

Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice
por: Wan, Jian, et al.
Publicado: (2019)

Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance
por: Steneberg, Pär, et al.
Publicado: (2015)

Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
por: van Zwol, Willemien, et al.
Publicado: (2023)

Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity
por: Zhang, Li, et al.
Publicado: (2014)

The Effect of Hepatosteatosis on Response to Antiviral Treatment in Patients with Chronic Hepatitis B: A Meta-Analysis
por: Zhu, Yongfen, et al.
Publicado: (2017)

The Bovine Hepatic Cell Line BFH12 as a Possible Model for Hepatosteatosis in Dairy Cows
por: Reichelt, Kristin, et al.
Publicado: (2022)

Identifying heterogeneity in the Hawthorne effect on hand hygiene observation: a cohort study of overtly and covertly observed results
por: Wu, Kuan-Sheng, et al.
Publicado: (2018)

A FATal AP-1 dimer switch in hepatosteatosis
por: Bakiri, Latifa, et al.
Publicado: (2014)

NTCP deficiency in mice protects against obesity and hepatosteatosis
por: Donkers, Joanne M., et al.
Publicado: (2019)

Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
por: Erman, Hande, et al.
Publicado: (2020)

Late-Onset Lipid Storage Myopathy with Fatal Hepatosteatosis
por: Yavuz, Arda, et al.
Publicado: (2020)

Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity
por: Hwang, Kyung-A, et al.
Publicado: (2015)

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota
por: Liu, Meng-Ting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2std3ksu31qm3b79rsbtmqqi7f